Impact of dexamethasone use to prevent from severe covid-19-induced acute kidney injury

HIGHLIGHTS

• who: Arthur Orieux from the To the editor Since the first wave of COVID-19, the management of patients with severe , in intensive care unit (ICU) has changed with the widespread use of dexamethasone (DXM) in severe patients [1]Indeed, RECOVERY trial [2] showed a decrease in both mortality at day , and the number of patients who received renal replacement therapy (RRT) with DXM. We have previously reported a higher than usual incidence of acute kidney injury (AKI) (80%) in severe , patients treated in ICU [3]. Like lung injury, specific SARS-Co, inflammatory process was previously suggested . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.